While many brain-computer interface companies are focused on helping paralyzed people communicate, Motif Neurotech is ...
FDA approved a request from Motif Neurotech, to start an initial feasibility trial to test a brain implant to treat ...
Interesting Engineering on MSN
FDA clears first US trial of wireless brain implant for treatment-resistant depression
A tiny brain implant, no bigger than a blueberry, is moving from lab concept ...
Motif’s study primarily aims to validate the safety of its XCS system over a 12-month period following implantation.
Motif Neurotech, a brain-computer interface (BCI) company developing technologies for mental health, today announced that the ...
Neurostimulation has been proven to help relieve symptoms of major depressive disorder—including otherwise difficult-to-treat cases of treatment-resistant depression, or TRD—though currently available ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results